Lemaitre Vascular (LMAT) Receivables (2010 - 2026)

Lemaitre Vascular (LMAT) has 17 years of Receivables data on file, last reported at $35.8 million in Q1 2026.

• Quarterly Receivables rose 1.87% year-over-year to $35.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $35.8 million (up 1.87% YoY) and the FY2025 annual result came in at $33.6 million, up 11.8% from the prior year.
• Receivables improved to $35.8 million in Q1 2026 per LMAT's latest filing, from $33.6 million in the prior quarter.
• Across five years, Receivables topped out at $36.5 million in Q2 2025 and bottomed at $20.1 million in Q3 2022.
• The 5-year median for Receivables is $30.1 million (2024), against an average of $28.4 million.
• The widest annual swing landed in 2024, when Receivables jumped 35.12%; it then grew 0.46% in 2025.
• Tracing LMAT's Receivables over 5 years: stood at $22.0 million in 2022, then rose by 13.72% to $25.1 million in 2023, then grew by 19.94% to $30.1 million in 2024, then increased by 11.8% to $33.6 million in 2025, then climbed by 6.43% to $35.8 million in 2026.
• Per Business Quant, the three latest LMAT Receivables figures stand at $35.8 million (Q1 2026), $33.6 million (Q4 2025), and $32.4 million (Q3 2025).

Peer Comparison